Gentex (GNTX) Financials

$21.97 +0.30 (+1.38%)

As of 04:00 PM Eastern

Annual Income Statements for Gentex

This table shows Gentex's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	318	348	407	438	425	348	361	319	428	404
Consolidated Net Income / (Loss)	318	348	407	438	425	348	361	319	428	404
Net Income / (Loss) Continuing Operations	318	348	407	438	425	348	361	319	428	404
Total Pre-Tax Income	464	511	532	522	500	412	416	370	505	472
Total Operating Income	459	512	523	508	489	400	410	370	496	460
Total Gross Profit	604	668	695	690	688	605	620	610	763	771
Total Revenue	1,544	1,679	1,795	1,834	1,859	1,688	1,731	1,919	2,299	2,313
Operating Revenue	1,544	1,679	1,795	1,834	1,859	1,688	1,731	1,919	2,299	2,313
Total Cost of Revenue	940	1,010	1,100	1,144	1,171	1,083	1,111	1,309	1,537	1,542
Operating Cost of Revenue	940	1,010	1,100	1,144	1,171	1,083	1,111	1,309	1,537	1,542
Total Operating Expenses	145	157	171	182	200	206	210	240	267	311
Selling, General & Admin Expense	57	62	71	75	85	90	92	106	113	121
Research & Development Expense	88	94	100	107	115	116	118	133	154	181
Impairment Charge	-	-	-	-	-	-	-	0.00	0.00	8.86
Total Other Income / (Expense), net	4.83	-1.18	8.44	14	12	12	6.57	-0.28	9.25	12
Interest & Investment Income	4.99	4.79	9.44	11	11	6.99	3.59	4.80	13	13
Other Income / (Expense), net	-0.17	-5.97	-1.00	2.66	0.65	5.27	2.98	-5.08	-4.25	-0.92
Income Tax Expense	145	163	125	84	76	64	56	51	77	68
Basic Earnings per Share	$1.09	$1.21	$1.42	$1.64	$1.67	$1.41	$1.51	$1.36	$1.84	$1.77
Weighted Average Basic Shares Outstanding	293.10M	288.43M	285.86M	267.79M	251.27M	243.67M	236.42M	234.18M	231.49M	227.20M
Diluted Earnings per Share	$1.08	$1.19	$1.41	$1.62	$1.66	$1.41	$1.50	$1.36	$1.84	$1.76
Weighted Average Diluted Shares Outstanding	293.10M	288.43M	285.86M	267.79M	251.27M	243.67M	236.42M	234.18M	231.49M	227.20M
Weighted Average Basic & Diluted Shares Outstanding	293.10M	288.43M	285.86M	267.79M	251.27M	243.67M	236.42M	234.18M	231.49M	227.20M
Cash Dividends to Common per Share	$0.34	$0.36	$0.39	$0.44	$0.46	$0.48	$0.48	$0.48	$0.48	$0.48

This table shows Gentex's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	73	86	98	109	105	117	108	86	123	88
Consolidated Net Income / (Loss)	73	86	98	109	105	117	108	86	123	88
Net Income / (Loss) Continuing Operations	73	86	98	109	105	117	108	86	123	88
Total Pre-Tax Income	86	95	116	129	124	136	128	101	145	98
Total Operating Income	87	94	113	127	122	133	129	115	126	90
Total Gross Profit	147	154	175	193	191	203	202	189	204	176
Total Revenue	494	494	551	583	576	589	590	573	609	542
Operating Revenue	494	494	551	583	576	589	590	573	609	542
Total Cost of Revenue	346	340	376	390	384	386	388	384	404	365
Operating Cost of Revenue	346	340	376	390	384	386	388	384	404	365
Total Operating Expenses	60	60	61	66	69	71	73	74	78	86
Selling, General & Admin Expense	27	25	27	28	29	29	31	30	30	31
Research & Development Expense	34	35	35	38	40	42	42	44	48	47
Total Other Income / (Expense), net	-0.63	2.14	2.74	1.31	2.06	3.13	-1.70	-14	20	8.01
Interest & Investment Income	1.50	-	2.94	2.89	3.85	3.82	-3.37	-12	19	10
Other Income / (Expense), net	-2.13	-0.24	-0.19	-1.58	-1.79	-0.69	1.67	-1.16	0.74	-2.17
Income Tax Expense	14	9.29	18	19	20	19	19	15	23	10
Basic Earnings per Share	$0.31	$0.37	$0.42	$0.47	$0.45	$0.50	$0.47	$0.37	$0.54	$0.39
Weighted Average Basic Shares Outstanding	234.58M	234.18M	233.70M	233.44M	233.25M	231.49M	231.18M	230.22M	227.43M	227.20M
Diluted Earnings per Share	$0.31	$0.37	$0.42	$0.47	$0.45	$0.50	$0.47	$0.37	$0.53	$0.39
Weighted Average Diluted Shares Outstanding	234.58M	234.18M	233.70M	233.44M	233.25M	231.49M	231.18M	230.22M	227.43M	227.20M
Weighted Average Basic & Diluted Shares Outstanding	234.58M	234.18M	233.70M	233.44M	233.25M	231.49M	231.18M	230.22M	227.43M	227.20M
Cash Dividends to Common per Share	$0.12	$0.12	$0.12	$0.12	$0.12	$0.12	$0.12	$0.12	$0.12	$0.12

This table details how cash moves in and out of Gentex's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	54	-5.08	23	-353	79	127	-161	-44	7.68	6.88
Net Cash From Operating Activities	354	477	501	552	506	464	362	338	537	498
Net Cash From Continuing Operating Activities	354	477	501	552	506	464	363	338	537	498
Net Income / (Loss) Continuing Operations	318	348	407	438	425	348	361	319	428	404
Consolidated Net Income / (Loss)	318	348	407	438	425	348	361	319	428	404
Depreciation Expense	81	89	100	102	105	105	99	97	93	95
Non-Cash Adjustments To Reconcile Net Income	15	20	18	16	22	29	27	32	45	52
Changes in Operating Assets and Liabilities, net	-60	21	-23	-3.48	-45	-16	-124	-109	-30	-53
Net Cash From Investing Activities	-90	-251	-78	-186	-57	26	-113	-173	-299	-202
Net Cash From Continuing Investing Activities	-90	-251	-78	-186	-57	26	-113	-173	-299	-202
Purchase of Property, Plant & Equipment	-98	-121	-104	-86	-85	-52	-69	-146	-184	-145
Acquisitions	-	-	-	0.00	0.00	-11	-25	0.00	-19	-2.87
Purchase of Investments	-48	-217	-30	-332	-153	-74	-100	-64	-152	-79
Sale of Property, Plant & Equipment	0.04	0.67	0.25	0.74	2.00	0.38	2.58	0.31	0.29	3.31
Sale and/or Maturity of Investments	59	93	53	237	182	167	84	41	76	59
Other Investing Activities, net	-2.84	-7.28	2.65	-5.60	-3.03	-4.33	-5.50	-4.00	-21	-38
Net Cash From Financing Activities	-211	-231	-400	-719	-370	-364	-410	-209	-230	-289
Net Cash From Continuing Financing Activities	-211	-231	-400	-719	-370	-364	-410	-209	-230	-289
Repurchase of Common Equity	-111	-163	-231	-592	-331	-288	-325	-113	-147	-206
Payment of Dividends	-97	-101	-109	-117	-116	-117	-115	-113	-112	-110
Issuance of Common Equity	30	81	48	67	78	42	30	17	29	27

This table details how cash moves in and out of Gentex's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-46	-4.18	0.70	18	23	-34	23	11	-81	54
Net Cash From Operating Activities	47	102	121	121	126	170	130	129	85	154
Net Cash From Continuing Operating Activities	47	102	121	121	126	170	130	129	85	154
Net Income / (Loss) Continuing Operations	73	86	98	109	105	117	108	86	123	88
Consolidated Net Income / (Loss)	73	86	98	109	105	117	108	86	123	88
Depreciation Expense	23	23	24	25	22	22	24	24	23	24
Non-Cash Adjustments To Reconcile Net Income	7.87	8.10	8.93	11	14	12	16	28	-4.71	12
Changes in Operating Assets and Liabilities, net	-57	-16	-9.63	-24	-15	18	-18	-9.14	-56	31
Net Cash From Investing Activities	-56	-53	-72	-54	-63	-110	-55	-47	-45	-55
Net Cash From Continuing Investing Activities	-56	-53	-72	-54	-63	-110	-55	-47	-45	-55
Purchase of Property, Plant & Equipment	-50	-38	-43	-47	-31	-62	-32	-32	-39	-42
Purchase of Investments	-5.80	-14	-32	-34	-47	-39	-38	-23	-23	5.02
Sale of Property, Plant & Equipment	0.05	0.22	0.12	0.02	0.05	0.11	0.01	0.12	0.02	3.17
Sale and/or Maturity of Investments	0.50	-	4.59	29	14	29	18	8.37	19	14
Other Investing Activities, net	-0.37	-1.68	-2.11	-1.38	0.95	-19	-3.29	-0.84	-1.49	-32
Net Cash From Financing Activities	-37	-53	-48	-49	-40	-93	-52	-71	-120	-46
Net Cash From Continuing Financing Activities	-37	-53	-48	-49	-40	-93	-52	-71	-120	-46
Repurchase of Common Equity	-13	-29	-26	-29	-23	-71	-41	-47	-97	-21
Payment of Dividends	-28	-28	-28	-28	-28	-28	-28	-28	-28	-27
Issuance of Common Equity	3.37	4.24	5.96	7.93	10	5.09	17	3.41	3.78	3.27

This table presents Gentex's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	2,149	2,310	2,352	2,085	2,169	2,198	2,131	2,327	2,611	2,761
Total Current Assets	984	1,155	1,185	851	950	979	873	949	998	1,037
Cash & Equivalents	552	546	570	217	296	423	262	215	226	233
Short-Term Investments	4.55	177	153	169	140	27	5.42	23	14	22
Accounts Receivable	196	212	231	214	235	285	250	276	322	295
Inventories, net	175	189	217	225	249	226	316	404	402	436
Prepaid Expenses	57	31	14	26	29	18	39	26	33	50
Plant, Property, & Equipment, net	413	466	492	498	498	468	464	550	653	728
Plant, Property & Equipment, gross	934	1,047	1,144	1,198	1,227	1,257	1,324	1,478	1,642	1,774
Accumulated Depreciation	521	581	652	699	729	789	860	928	989	1,046
Total Noncurrent Assets	752	689	675	1,472	720	750	794	829	961	995
Long-Term Investments	95	50	58	138	140	162	208	202	299	340
Goodwill	307	307	307	307	307	312	314	314	340	341
Intangible Assets	349	332	310	291	273	250	239	219	214	195
Noncurrent Deferred & Refundable Income Taxes	-	-	-	-	-	-	4.80	26	41	53
Other Noncurrent Operating Assets	-	-	-	736	-	27	29	68	67	66
Total Liabilities & Shareholders' Equity	2,149	2,310	2,352	2,085	2,169	2,198	2,131	2,327	2,611	2,761
Total Liabilities	426	399	303	224	231	234	193	261	299	289
Total Current Liabilities	131	150	244	169	172	178	182	251	272	253
Accounts Payable	66	80	90	93	98	85	98	152	184	168
Accrued Expenses	23	24	29	28	29	41	41	34	36	37
Dividends Payable	25	26	28	29	29	29	28	28	28	27
Current Deferred & Payable Income Tax Liabilities	0.15	0.57	0.36	4.29	0.02	3.79	0.20	19	0.69	0.44
Current Employee Benefit Liabilities	9.32	12	19	16	16	19	14	18	23	20
Total Noncurrent Liabilities	295	249	59	55	59	56	12	11	27	36
Other Noncurrent Operating Liabilities	-	-	-	0.00	7.41	17	12	11	27	36
Total Equity & Noncontrolling Interests	1,723	1,910	2,050	1,862	1,938	1,964	1,938	2,066	2,313	2,472
Total Preferred & Common Equity	1,723	1,910	2,050	1,862	1,938	1,964	1,938	2,066	2,313	2,468
Total Common Equity	1,723	1,910	2,050	1,862	1,938	1,964	1,938	2,066	2,313	2,468
Common Stock	614	701	740	761	823	867	894	932	982	1,024
Retained Earnings	1,109	1,211	1,302	1,102	1,116	1,090	1,042	1,148	1,337	1,450
Accumulated Other Comprehensive Income / (Loss)	-1.13	-1.27	7.19	-1.60	-1.29	6.85	1.93	-14	-6.56	-6.41
Noncontrolling Interest	-	-	-	-	-	-	-	-	0.00	4.15

This table presents Gentex's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	2,311	2,433	2,487	2,558	2,713	2,738	2,735
Total Current Assets	989	1,005	1,025	1,055	1,073	1,084	1,046
Cash & Equivalents	223	215	238	261	249	260	180
Short-Term Investments	16	26	20	17	17	16	20
Accounts Receivable	292	333	350	351	342	307	356
Inventories, net	418	402	390	395	437	463	449
Prepaid Expenses	40	25	27	31	29	38	40
Plant, Property, & Equipment, net	527	575	597	606	665	679	704
Total Noncurrent Assets	795	853	865	897	976	975	986
Long-Term Investments	194	229	240	273	311	308	326
Goodwill	314	314	314	313	340	340	340
Intangible Assets	224	215	210	205	210	206	202
Noncurrent Deferred & Refundable Income Taxes	-	24	29	37	45	52	50
Other Noncurrent Operating Assets	63	72	73	70	70	69	69
Total Liabilities & Shareholders' Equity	2,311	2,433	2,487	2,558	2,713	2,738	2,735
Total Liabilities	277	310	291	290	337	338	318
Total Current Liabilities	265	297	276	274	304	305	283
Accounts Payable	171	167	168	171	192	206	183
Accrued Expenses	94	130	108	103	113	99	101
Total Noncurrent Liabilities	12	13	15	15	32	33	35
Other Noncurrent Operating Liabilities	12	13	15	15	32	33	35
Total Equity & Noncontrolling Interests	2,034	2,123	2,196	2,268	2,376	2,400	2,418
Total Preferred & Common Equity	2,034	2,123	2,196	2,268	2,376	2,400	2,418
Total Common Equity	2,034	2,123	2,196	2,268	2,376	2,400	2,418
Common Stock	923	942	957	975	1,005	1,014	1,015
Retained Earnings	1,108	1,193	1,253	1,307	1,379	1,394	1,406
Accumulated Other Comprehensive Income / (Loss)	3.29	-12	-13	-14	-7.47	-7.98	-2.89

This table displays calculated financial ratios and metrics derived from Gentex's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	12.22%	8.77%	6.91%	2.18%	1.35%	-9.18%	2.55%	10.85%	19.82%	0.61%
EBITDA Growth	10.79%	10.23%	4.64%	-1.44%	-3.11%	-14.20%	0.45%	-9.84%	26.72%	-5.35%
EBIT Growth	12.04%	10.29%	3.28%	-2.21%	-4.23%	-17.24%	1.96%	-11.59%	34.68%	-6.65%
NOPAT Growth	13.72%	10.55%	14.91%	6.46%	-2.72%	-18.66%	5.30%	-10.17%	31.84%	-6.36%
Net Income Growth	10.35%	9.14%	17.03%	7.64%	-3.01%	-18.16%	3.81%	-11.65%	34.40%	-5.58%
EPS Growth	10.20%	10.19%	18.49%	14.89%	2.47%	-15.06%	6.38%	-9.33%	35.29%	-4.35%
Operating Cash Flow Growth	8.31%	34.60%	5.02%	10.26%	-8.41%	-8.20%	-22.03%	-6.62%	58.86%	-7.27%
Free Cash Flow Firm Growth	0.66%	40.23%	13.50%	-180.40%	475.10%	-69.19%	-29.45%	-34.58%	68.57%	7.46%
Invested Capital Growth	6.45%	1.46%	2.00%	52.81%	-33.85%	-0.70%	7.99%	10.66%	9.13%	5.76%
Revenue Q/Q Growth	3.71%	0.86%	2.26%	-0.33%	-0.51%	5.37%	-5.98%	4.00%	4.33%	-2.01%
EBITDA Q/Q Growth	5.00%	0.69%	2.02%	-1.57%	-2.06%	11.85%	-13.47%	1.39%	6.80%	-7.21%
EBIT Q/Q Growth	6.11%	0.24%	1.42%	-1.25%	-3.25%	15.09%	-15.79%	1.97%	8.43%	-8.84%
NOPAT Q/Q Growth	6.68%	0.28%	10.80%	-5.48%	-1.14%	14.81%	-14.00%	0.65%	7.49%	-7.84%
Net Income Q/Q Growth	5.79%	0.11%	11.42%	-5.24%	-1.56%	14.42%	-14.09%	0.63%	7.74%	-6.75%
EPS Q/Q Growth	4.85%	-1.65%	9.30%	-3.57%	0.00%	14.63%	-12.79%	0.74%	7.60%	-5.88%
Operating Cash Flow Q/Q Growth	-7.45%	11.55%	5.88%	1.05%	-5.98%	2.98%	-16.71%	13.06%	14.43%	-2.96%
Free Cash Flow Firm Q/Q Growth	-14.90%	17.49%	-14.04%	-193.52%	160.54%	3.19%	-22.38%	31.12%	-1.62%	14.62%
Invested Capital Q/Q Growth	7.22%	3.18%	11.47%	54.12%	2.91%	5.51%	6.04%	3.06%	4.81%	0.64%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	39.11%	39.81%	38.70%	37.65%	37.03%	35.86%	35.80%	31.78%	33.17%	33.33%
EBITDA Margin	34.93%	35.40%	34.65%	33.42%	31.95%	30.18%	29.57%	24.05%	25.43%	23.93%
Operating Margin	29.72%	30.48%	29.16%	27.70%	26.28%	23.67%	23.67%	19.28%	21.56%	19.87%
EBIT Margin	29.71%	30.12%	29.10%	27.85%	26.32%	23.98%	23.84%	19.02%	21.38%	19.83%
Profit (Net Income) Margin	20.63%	20.70%	22.66%	23.88%	22.85%	20.59%	20.84%	16.61%	18.63%	17.49%
Tax Burden Percent	68.70%	68.08%	76.49%	83.88%	84.87%	84.40%	86.66%	86.22%	84.84%	85.66%
Interest Burden Percent	101.09%	100.95%	101.81%	102.20%	102.30%	101.73%	100.87%	101.31%	102.75%	102.92%
Effective Tax Rate	31.30%	31.92%	23.51%	16.12%	15.13%	15.60%	13.34%	13.78%	15.16%	14.34%
Return on Invested Capital (ROIC)	24.45%	26.02%	29.39%	24.51%	23.74%	24.34%	24.73%	20.31%	24.38%	21.26%
ROIC Less NNEP Spread (ROIC-NNEP)	23.53%	26.19%	28.35%	19.13%	17.19%	22.51%	23.63%	20.37%	22.69%	19.28%
Return on Net Nonoperating Assets (RNNOA)	-5.12%	-6.89%	-8.85%	-2.12%	-1.39%	-6.52%	-6.24%	-4.39%	-4.81%	-4.35%
Return on Equity (ROE)	19.34%	19.14%	20.55%	22.39%	22.35%	17.81%	18.49%	15.92%	19.57%	16.91%
Cash Return on Invested Capital (CROIC)	18.20%	24.57%	27.42%	-17.27%	64.49%	25.04%	17.05%	10.20%	15.65%	15.66%
Operating Return on Assets (OROA)	21.99%	22.69%	22.41%	23.02%	23.00%	18.54%	19.07%	16.37%	19.90%	17.08%
Return on Assets (ROA)	15.27%	15.59%	17.45%	19.74%	19.97%	15.92%	16.67%	14.30%	17.35%	15.06%
Return on Common Equity (ROCE)	19.34%	19.14%	20.55%	22.39%	22.35%	17.81%	18.49%	15.92%	19.57%	16.89%
Return on Equity Simple (ROE_SIMPLE)	18.49%	18.19%	19.85%	23.52%	21.91%	17.70%	18.62%	15.43%	18.53%	16.39%
Net Operating Profit after Tax (NOPAT)	315	348	400	426	415	337	355	319	421	394
NOPAT Margin	20.42%	20.75%	22.30%	23.24%	22.30%	19.98%	20.51%	16.62%	18.29%	17.02%
Net Nonoperating Expense Percent (NNEP)	0.93%	-0.17%	1.04%	5.38%	6.56%	1.83%	1.11%	-0.06%	1.69%	1.98%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	15.44%	18.19%	15.93%
Cost of Revenue to Revenue	60.89%	60.19%	61.30%	62.35%	62.97%	64.14%	64.20%	68.22%	66.83%	66.67%
SG&A Expenses to Revenue	3.67%	3.72%	3.98%	4.10%	4.58%	5.33%	5.32%	5.55%	4.89%	5.23%
R&D to Revenue	5.73%	5.61%	5.56%	5.84%	6.17%	6.87%	6.80%	6.95%	6.71%	7.84%
Operating Expenses to Revenue	9.39%	9.33%	9.54%	9.94%	10.75%	12.20%	12.13%	12.50%	11.61%	13.46%
Earnings before Interest and Taxes (EBIT)	459	506	522	511	489	405	413	365	491	459
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	539	594	622	613	594	510	512	461	585	554
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.32	2.58	2.59	2.58	3.51	4.00	4.07	2.99	3.23	2.64
Price to Tangible Book Value (P/TBV)	3.74	3.88	3.70	3.81	5.00	5.60	5.70	4.03	4.25	3.37
Price to Revenue (P/Rev)	2.59	2.94	2.95	2.62	3.65	4.65	4.56	3.22	3.25	2.81
Price to Earnings (P/E)	12.53	14.19	13.03	10.99	16.00	22.58	21.86	19.36	17.44	16.08
Dividend Yield	2.41%	2.03%	2.04%	2.34%	1.69%	1.48%	1.44%	1.82%	1.50%	1.68%
Earnings Yield	7.98%	7.05%	7.68%	9.10%	6.25%	4.43%	4.57%	5.16%	5.73%	6.22%
Enterprise Value to Invested Capital (EV/IC)	2.69	3.22	3.34	2.04	4.47	5.24	4.97	3.47	3.85	3.11
Enterprise Value to Revenue (EV/Rev)	2.31	2.59	2.56	2.34	3.34	4.29	4.28	2.99	3.02	2.56
Enterprise Value to EBITDA (EV/EBITDA)	6.63	7.31	7.39	6.99	10.47	14.20	14.48	12.41	11.85	10.69
Enterprise Value to EBIT (EV/EBIT)	7.79	8.59	8.80	8.39	12.71	17.87	17.96	15.70	14.11	12.89
Enterprise Value to NOPAT (EV/NOPAT)	11.34	12.47	11.48	10.06	15.00	21.45	20.87	17.96	16.48	15.02
Enterprise Value to Operating Cash Flow (EV/OCF)	10.08	9.10	9.17	7.76	12.29	15.57	20.47	16.94	12.90	11.87
Enterprise Value to Free Cash Flow (EV/FCFF)	15.23	13.20	12.31	0.00	5.52	20.85	30.28	35.77	25.68	20.39
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.14	0.10	0.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.13	0.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.22	-0.26	-0.31	-0.11	-0.08	-0.29	-0.26	-0.22	-0.21	-0.23
Leverage Ratio	1.27	1.23	1.18	1.13	1.12	1.12	1.11	1.11	1.13	1.12
Compound Leverage Factor	1.28	1.24	1.20	1.16	1.15	1.14	1.12	1.13	1.16	1.16
Debt to Total Capital	11.92%	8.86%	3.67%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.38%	0.36%	3.67%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	11.54%	8.50%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.17%
Common Equity to Total Capital	88.08%	91.14%	96.33%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	99.83%
Debt to EBITDA	0.43	0.31	0.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	-0.78	-0.99	-1.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.42	0.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.74	0.53	0.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	-1.33	-1.69	-1.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.72	0.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	8.24	10.12	13.26	15.73	20.42	22.63	27.00	16.56	17.55	15.98
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.09%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	7.51	7.71	4.86	5.03	5.53	5.51	4.81	3.79	3.67	4.11
Quick Ratio	5.74	6.24	3.91	3.55	3.91	4.14	2.85	2.05	2.07	2.18
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	235	329	373	-300	1,126	347	245	160	270	290
Operating Cash Flow to CapEx	362.03%	396.58%	482.70%	647.98%	612.71%	905.03%	546.61%	231.46%	292.96%	352.45%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.74	0.75	0.77	0.83	0.87	0.77	0.80	0.86	0.93	0.86
Accounts Receivable Turnover	8.48	8.24	8.11	8.25	8.28	6.49	6.48	7.29	7.69	7.50
Inventory Turnover	5.94	5.55	5.42	5.17	4.94	4.56	4.10	3.63	3.81	3.68
Fixed Asset Turnover	3.93	3.82	3.75	3.70	3.73	3.49	3.71	3.78	3.82	3.35
Accounts Payable Turnover	13.64	13.81	12.96	12.52	12.30	11.88	12.14	10.47	9.14	8.74
Days Sales Outstanding (DSO)	43.03	44.30	45.01	44.25	44.08	56.25	56.37	50.05	47.49	48.69
Days Inventory Outstanding (DIO)	61.45	65.74	67.35	70.54	73.93	80.10	89.09	100.46	95.83	99.28
Days Payable Outstanding (DPO)	26.76	26.43	28.17	29.16	29.68	30.73	30.07	34.86	39.92	41.74
Cash Conversion Cycle (CCC)	77.72	83.62	84.19	85.63	88.33	105.62	115.39	115.65	103.39	106.23
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,329	1,349	1,375	2,102	1,390	1,381	1,491	1,650	1,800	1,904
Invested Capital Turnover	1.20	1.25	1.32	1.05	1.06	1.22	1.21	1.22	1.33	1.25
Increase / (Decrease) in Invested Capital	81	19	27	726	-712	-9.75	110	159	151	104
Enterprise Value (EV)	3,573	4,343	4,597	4,287	6,217	7,234	7,412	5,728	6,933	5,915
Market Capitalization	3,991	4,931	5,299	4,812	6,794	7,846	7,888	6,172	7,473	6,506
Book Value per Share	$5.91	$6.67	$7.22	$7.10	$7.66	$8.01	$8.19	$8.81	$9.91	$10.85
Tangible Book Value per Share	$3.66	$4.44	$5.05	$4.82	$5.37	$5.72	$5.86	$6.53	$7.54	$8.50
Total Capital	1,956	2,096	2,128	1,862	1,938	1,964	1,938	2,066	2,313	2,472
Total Debt	233	186	78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	226	178	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-418	-588	-702	-524	-577	-613	-475	-444	-540	-595
Capital Expenditures (CapEx)	98	120	104	85	83	51	66	146	183	141
Debt-free, Cash-free Net Working Capital (DFCFNWC)	304	289	297	295	342	351	424	456	485	529
Debt-free Net Working Capital (DFNWC)	861	1,013	1,019	682	779	802	691	698	726	785
Net Working Capital (NWC)	853	1,005	941	682	779	802	691	698	726	785
Net Nonoperating Expense (NNE)	-3.31	0.80	-6.45	-12	-10	-10	-5.69	0.24	-7.85	-11
Net Nonoperating Obligations (NNO)	-393	-562	-674	240	-548	-583	-447	-416	-512	-568
Total Depreciation and Amortization (D&A)	81	89	100	102	105	105	99	97	93	95
Debt-free, Cash-free Net Working Capital to Revenue	19.72%	17.22%	16.53%	16.10%	18.39%	20.80%	24.47%	23.78%	21.11%	22.87%
Debt-free Net Working Capital to Revenue	55.75%	60.31%	56.77%	37.17%	41.88%	47.48%	39.93%	36.38%	31.58%	33.92%
Net Working Capital to Revenue	55.26%	59.87%	52.42%	37.17%	41.88%	47.48%	39.93%	36.38%	31.58%	33.92%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.09	$1.21	$1.42	$1.64	$1.67	$1.41	$1.51	$1.36	$1.84	$1.77
Adjusted Weighted Average Basic Shares Outstanding	288.89M	287.30M	274.42M	259.23M	251.27M	243.67M	236.42M	234.18M	231.49M	227.20M
Adjusted Diluted Earnings per Share	$1.08	$1.19	$1.41	$1.62	$1.66	$1.41	$1.50	$1.36	$1.84	$1.76
Adjusted Weighted Average Diluted Shares Outstanding	288.89M	287.30M	274.42M	259.23M	251.27M	243.67M	236.42M	234.18M	231.49M	227.20M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	288.89M	287.30M	274.42M	259.23M	251.27M	243.67M	236.42M	234.18M	231.49M	227.20M
Normalized Net Operating Profit after Tax (NOPAT)	315	348	400	426	415	337	355	319	421	401
Normalized NOPAT Margin	20.42%	20.75%	22.30%	23.24%	22.30%	19.98%	20.51%	16.62%	18.29%	17.35%
Pre Tax Income Margin	30.03%	30.41%	29.63%	28.46%	26.92%	24.39%	24.05%	19.27%	21.96%	20.41%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	30.46%	29.09%	26.75%	26.62%	27.39%	33.72%	31.95%	35.48%	26.18%	27.30%
Augmented Payout Ratio	65.38%	76.09%	83.62%	161.72%	105.44%	116.72%	121.93%	70.78%	60.59%	78.26%

This table displays calculated financial ratios and metrics derived from Gentex's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	23.53%	17.58%	17.62%	25.91%	16.65%	19.34%	7.17%	-1.81%	5.67%	-8.06%
EBITDA Growth	-5.66%	5.69%	7.77%	37.80%	32.33%	31.79%	13.04%	-8.50%	4.64%	-27.84%
EBIT Growth	-6.72%	8.11%	10.30%	49.86%	42.48%	40.70%	15.89%	-9.54%	4.85%	-33.68%
NOPAT Growth	-2.66%	2.55%	8.83%	47.51%	40.72%	34.48%	15.12%	-9.71%	2.85%	-29.56%
Net Income Growth	-5.22%	2.36%	11.48%	50.76%	44.14%	35.72%	10.92%	-21.18%	17.02%	-25.03%
EPS Growth	-3.13%	2.78%	13.51%	51.61%	45.16%	35.14%	11.90%	-21.28%	17.78%	-22.00%
Operating Cash Flow Growth	-0.09%	62.21%	4.27%	64.87%	167.33%	66.51%	7.41%	6.95%	-32.73%	-8.95%
Free Cash Flow Firm Growth	-444.27%	-169.10%	-19.37%	-5.92%	88.60%	50.79%	52.70%	75.35%	-392.36%	36.12%
Invested Capital Growth	13.86%	10.66%	12.43%	12.66%	7.30%	9.13%	9.15%	6.95%	10.14%	5.76%
Revenue Q/Q Growth	6.52%	0.00%	11.57%	5.94%	-1.31%	2.31%	0.19%	-2.93%	6.21%	-10.99%
EBITDA Q/Q Growth	-1.21%	8.58%	17.02%	9.79%	-5.13%	8.14%	0.37%	-11.14%	8.50%	-25.43%
EBIT Q/Q Growth	0.93%	10.88%	20.43%	11.20%	-4.04%	9.50%	-0.81%	-13.20%	11.21%	-30.74%
NOPAT Q/Q Growth	-0.08%	16.09%	12.14%	13.40%	-4.67%	10.94%	-4.01%	-11.05%	8.59%	-24.02%
Net Income Q/Q Growth	0.35%	18.60%	13.24%	11.86%	-4.06%	11.67%	-7.45%	-20.50%	42.43%	-28.46%
EPS Q/Q Growth	0.00%	19.35%	13.51%	11.90%	-4.26%	11.11%	-6.00%	-21.28%	43.24%	-26.42%
Operating Cash Flow Q/Q Growth	-35.75%	116.24%	18.73%	-0.05%	4.18%	34.69%	-23.41%	-0.48%	-34.48%	82.31%
Free Cash Flow Firm Q/Q Growth	-55.44%	39.24%	-17.65%	4.68%	83.26%	-162.18%	-378.68%	50.32%	-234.24%	65.98%
Invested Capital Q/Q Growth	6.19%	3.06%	-0.06%	3.02%	1.13%	4.81%	1.52%	0.94%	4.16%	0.64%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	29.82%	31.16%	31.73%	33.09%	33.25%	34.52%	34.26%	32.91%	33.53%	32.54%
EBITDA Margin	21.86%	23.73%	24.89%	25.80%	24.80%	26.21%	26.26%	24.04%	24.55%	20.57%
Operating Margin	17.58%	19.07%	20.56%	21.82%	21.26%	22.54%	21.91%	20.05%	20.66%	16.57%
EBIT Margin	17.15%	19.02%	20.53%	21.55%	20.95%	22.42%	22.20%	19.85%	20.78%	16.17%
Profit (Net Income) Margin	14.72%	17.46%	17.72%	18.71%	18.19%	19.85%	18.34%	15.02%	20.14%	16.19%
Tax Burden Percent	84.32%	90.27%	84.12%	84.88%	84.13%	86.05%	84.79%	84.91%	84.25%	89.66%
Interest Burden Percent	101.77%	101.68%	102.60%	102.30%	103.19%	102.89%	97.43%	89.10%	115.01%	111.62%
Effective Tax Rate	15.68%	9.73%	15.88%	15.12%	15.87%	13.95%	15.21%	15.09%	15.75%	10.34%
Return on Invested Capital (ROIC)	18.20%	21.03%	22.23%	24.51%	23.75%	25.85%	25.20%	22.55%	22.77%	18.56%
ROIC Less NNEP Spread (ROIC-NNEP)	18.31%	20.75%	21.73%	24.28%	23.40%	25.27%	25.48%	24.68%	19.68%	17.23%
Return on Net Nonoperating Assets (RNNOA)	-4.27%	-4.47%	-5.03%	-5.67%	-5.35%	-5.36%	-5.95%	-5.81%	-4.52%	-3.89%
Return on Equity (ROE)	13.92%	16.56%	17.20%	18.84%	18.40%	20.49%	19.25%	16.75%	18.25%	14.67%
Cash Return on Invested Capital (CROIC)	8.12%	10.20%	9.27%	10.64%	16.54%	15.65%	16.48%	17.44%	14.02%	15.66%
Operating Return on Assets (OROA)	14.29%	16.37%	17.81%	19.16%	18.96%	20.88%	20.17%	17.69%	18.54%	13.93%
Return on Assets (ROA)	12.27%	15.03%	15.37%	16.64%	16.46%	18.48%	16.67%	13.38%	17.96%	13.94%
Return on Common Equity (ROCE)	13.92%	16.56%	17.20%	18.84%	18.40%	20.49%	19.25%	16.75%	18.25%	14.66%
Return on Equity Simple (ROE_SIMPLE)	15.57%	0.00%	15.49%	16.65%	17.53%	0.00%	18.48%	17.33%	17.94%	0.00%
Net Operating Profit after Tax (NOPAT)	73	85	95	108	103	114	110	98	106	80
NOPAT Margin	14.83%	17.21%	17.30%	18.52%	17.88%	19.39%	18.58%	17.03%	17.41%	14.86%
Net Nonoperating Expense Percent (NNEP)	-0.12%	0.28%	0.49%	0.23%	0.35%	0.58%	-0.27%	-2.13%	3.09%	1.33%
Return On Investment Capital (ROIC_SIMPLE)	-	4.11%	-	-	-	4.94%	-	-	-	3.26%
Cost of Revenue to Revenue	70.18%	68.84%	68.27%	66.91%	66.76%	65.48%	65.74%	67.09%	66.47%	67.46%
SG&A Expenses to Revenue	5.44%	5.02%	4.87%	4.77%	5.01%	4.93%	5.20%	5.18%	4.95%	5.64%
R&D to Revenue	6.79%	7.08%	6.29%	6.51%	6.98%	7.05%	7.15%	7.68%	7.93%	8.69%
Operating Expenses to Revenue	12.24%	12.10%	11.16%	11.28%	11.99%	11.98%	12.35%	12.86%	12.87%	15.96%
Earnings before Interest and Taxes (EBIT)	85	94	113	126	121	132	131	114	126	88
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	108	117	137	151	143	154	155	138	149	111
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.67	2.99	3.02	3.06	3.29	3.23	3.52	3.24	2.82	2.64
Price to Tangible Book Value (P/TBV)	3.63	4.03	4.02	4.01	4.26	4.25	4.58	4.19	3.63	3.37
Price to Revenue (P/Rev)	2.94	3.22	3.21	3.16	3.38	3.25	3.58	3.34	2.88	2.81
Price to Earnings (P/E)	17.14	19.36	19.51	18.36	18.75	17.44	19.06	18.67	15.69	16.08
Dividend Yield	2.08%	1.82%	1.75%	1.67%	1.50%	1.50%	1.34%	1.43%	1.62%	1.68%
Earnings Yield	5.84%	5.16%	5.13%	5.45%	5.33%	5.73%	5.25%	5.36%	6.37%	6.22%
Enterprise Value to Invested Capital (EV/IC)	3.12	3.47	3.60	3.66	4.02	3.85	4.33	3.95	3.32	3.11
Enterprise Value to Revenue (EV/Rev)	2.71	2.99	2.97	2.93	3.13	3.02	3.33	3.08	2.66	2.56
Enterprise Value to EBITDA (EV/EBITDA)	10.97	12.41	12.60	12.12	12.61	11.85	12.93	12.17	10.53	10.69
Enterprise Value to EBIT (EV/EBIT)	13.96	15.70	15.82	14.89	15.23	14.11	15.29	14.44	12.48	12.89
Enterprise Value to NOPAT (EV/NOPAT)	15.76	17.96	18.18	17.19	17.65	16.48	17.91	16.92	14.70	15.02
Enterprise Value to Operating Cash Flow (EV/OCF)	16.70	16.94	17.31	15.91	14.71	12.90	14.26	12.95	12.23	11.87
Enterprise Value to Free Cash Flow (EV/FCFF)	40.91	35.77	41.12	36.44	25.16	25.68	27.41	23.43	24.82	20.39
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.23	-0.22	-0.23	-0.23	-0.23	-0.21	-0.23	-0.24	-0.23	-0.23
Leverage Ratio	1.13	1.11	1.14	1.14	1.13	1.13	1.14	1.14	1.13	1.12
Compound Leverage Factor	1.15	1.13	1.17	1.17	1.17	1.16	1.11	1.01	1.30	1.25
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.17%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	99.83%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	13.71	16.17	14.42	15.92	17.53	17.10	16.98	15.83	14.93	15.54
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.09%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.73	3.79	3.38	3.71	3.85	3.67	3.52	3.56	3.69	4.11
Quick Ratio	2.00	2.05	1.93	2.20	2.29	2.07	2.00	1.91	1.97	2.18
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-122	-74	-87	-83	-14	-36	-41	-20	-68	-23
Operating Cash Flow to CapEx	93.39%	269.89%	283.17%	254.76%	405.21%	272.74%	407.63%	408.43%	215.41%	400.67%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.83	0.86	0.87	0.89	0.91	0.93	0.91	0.89	0.89	0.86
Accounts Receivable Turnover	6.92	7.29	6.52	6.79	6.85	7.69	6.94	7.09	6.67	7.50
Inventory Turnover	3.50	3.63	3.60	3.71	3.66	3.81	3.69	3.61	3.70	3.68
Fixed Asset Turnover	3.77	3.78	3.84	3.91	3.89	3.82	3.77	3.65	3.60	3.35
Accounts Payable Turnover	9.16	10.47	8.95	8.18	8.70	9.14	8.64	8.24	8.83	8.74
Days Sales Outstanding (DSO)	52.78	50.05	56.02	53.75	53.30	47.49	52.63	51.50	54.69	48.69
Days Inventory Outstanding (DIO)	104.18	100.46	101.30	98.32	99.63	95.83	98.80	100.98	98.66	99.28
Days Payable Outstanding (DPO)	39.86	34.86	40.79	44.61	41.97	39.92	42.27	44.30	41.34	41.74
Cash Conversion Cycle (CCC)	117.11	115.65	116.53	107.46	110.95	103.39	109.16	108.18	112.01	106.23
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,601	1,650	1,649	1,698	1,718	1,800	1,800	1,816	1,892	1,904
Invested Capital Turnover	1.23	1.22	1.28	1.32	1.33	1.33	1.36	1.32	1.31	1.25
Increase / (Decrease) in Invested Capital	195	159	182	191	117	151	151	118	174	104
Enterprise Value (EV)	4,996	5,728	5,941	6,215	6,905	6,933	7,790	7,182	6,281	5,915
Market Capitalization	5,429	6,172	6,415	6,712	7,455	7,473	8,367	7,766	6,807	6,506
Book Value per Share	$8.65	$8.81	$9.07	$9.40	$9.72	$9.91	$10.28	$10.38	$10.50	$10.85
Tangible Book Value per Share	$6.36	$6.53	$6.81	$7.16	$7.50	$7.54	$7.90	$8.02	$8.15	$8.50
Total Capital	2,034	2,066	2,123	2,196	2,268	2,313	2,376	2,400	2,418	2,472
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-433	-444	-474	-497	-551	-540	-577	-584	-526	-595
Capital Expenditures (CapEx)	50	38	43	47	31	62	32	32	39	39
Debt-free, Cash-free Net Working Capital (DFCFNWC)	485	456	463	491	503	485	502	503	562	529
Debt-free Net Working Capital (DFNWC)	724	698	708	749	781	726	768	779	763	785
Net Working Capital (NWC)	724	698	708	749	781	726	768	779	763	785
Net Nonoperating Expense (NNE)	0.53	-1.21	-2.31	-1.12	-1.74	-2.69	1.44	12	-17	-7.18
Net Nonoperating Obligations (NNO)	-433	-416	-474	-497	-551	-512	-577	-584	-526	-568
Total Depreciation and Amortization (D&A)	23	23	24	25	22	22	24	24	23	24
Debt-free, Cash-free Net Working Capital to Revenue	26.29%	23.78%	23.13%	23.16%	22.82%	21.11%	21.48%	21.62%	23.82%	22.87%
Debt-free Net Working Capital to Revenue	39.25%	36.38%	35.37%	35.32%	35.44%	31.58%	32.85%	33.47%	32.30%	33.92%
Net Working Capital to Revenue	39.25%	36.38%	35.37%	35.32%	35.44%	31.58%	32.85%	33.47%	32.30%	33.92%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.31	$0.37	$0.42	$0.47	$0.45	$0.50	$0.47	$0.37	$0.54	$0.39
Adjusted Weighted Average Basic Shares Outstanding	234.58M	234.18M	233.70M	233.44M	233.25M	231.49M	231.18M	230.22M	227.43M	227.20M
Adjusted Diluted Earnings per Share	$0.31	$0.37	$0.42	$0.47	$0.45	$0.50	$0.47	$0.37	$0.53	$0.39
Adjusted Weighted Average Diluted Shares Outstanding	234.58M	234.18M	233.70M	233.44M	233.25M	231.49M	231.18M	230.22M	227.43M	227.20M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	234.58M	234.18M	233.70M	233.44M	233.25M	231.49M	231.18M	230.22M	227.43M	227.20M
Normalized Net Operating Profit after Tax (NOPAT)	73	85	95	108	103	114	110	98	106	80
Normalized NOPAT Margin	14.83%	17.21%	17.30%	18.52%	17.88%	19.39%	18.58%	17.03%	17.41%	14.86%
Pre Tax Income Margin	17.45%	19.34%	21.06%	22.04%	21.62%	23.07%	21.63%	17.69%	23.90%	18.05%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	35.78%	35.48%	34.25%	30.78%	28.25%	26.18%	25.47%	26.81%	25.62%	27.30%
Augmented Payout Ratio	68.70%	70.78%	54.61%	56.90%	54.79%	60.59%	62.58%	70.37%	84.44%	78.26%

Frequently Asked Questions About Gentex's Financials

When does Gentex's financial year end?

According to the most recent income statement we have on file, Gentex's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Gentex's net income changed over the last 9 years?

In the past 9 years, Gentex's net income has ranged from $318.47 million in 2015 to $437.88 million in 2018, and is currently $404.49 million as of their latest financial filing in 2024.

What is Gentex's operating income?

Gentex's total operating income in 2024 was $459.73 million, based on the following breakdown:

Total Gross Profit: $771.09 million
Total Operating Expenses: $311.36 million

How has Gentex revenue changed over the last 9 years?

Over the last 9 years, Gentex's total revenue changed from $1.54 billion in 2015 to $2.31 billion in 2024, a change of 49.9%.

How much debt does Gentex have?

Gentex's total liabilities were at $288.72 million at the end of 2024, a 3.4% decrease from 2023, and a 32.2% decrease since 2015.

How much cash does Gentex have?

In the past 9 years, Gentex's cash and equivalents has ranged from $214.75 million in 2022 to $569.73 million in 2017, and is currently $233.32 million as of their latest financial filing in 2024.

How has Gentex's book value per share changed over the last 9 years?

Over the last 9 years, Gentex's book value per share changed from 5.91 in 2015 to 10.85 in 2024, a change of 83.7%.

Related Companies

This page (NASDAQ:GNTX) was last updated on 4/24/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Gentex (GNTX) Financials

Frequently Asked Questions About Gentex's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Gentex (GNTX) Financials

Annual Income Statements for Gentex

Quarterly Income Statements for Gentex

Annual Cash Flow Statements for Gentex

Quarterly Cash Flow Statements for Gentex

Annual Balance Sheets for Gentex

Quarterly Balance Sheets for Gentex

Annual Metrics and Ratios for Gentex

Quarterly Metrics and Ratios for Gentex

Frequently Asked Questions About Gentex's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools